Bank Julius Baer & Co
BIIB icon

Bank Julius Baer & Co’s Biogen BIIB Stock Holding History

Bank Julius Baer & Co’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$7.35K Hold
40
– – ﹤0.01% 654
2025
Q4 		$7.04K Hold
40
– – ﹤0.01% 623
2025
Q3 		$5.61K Hold
40
– – ﹤0.01% 638
2025
Q2 		$5.03K Hold
40
– – ﹤0.01% 593
2025
Q1 		$5.47K Buy
40
+4
+11% +$572 ﹤0.01% 590
2024
Q4 		$6.1K Buy
36
+2
+6% +$337 ﹤0.01% 611
2024
Q3 		$7.73K Sell
34
-819
-96% -$171K ﹤0.01% 499
2024
Q2 		$220K Sell
853
-1,155
-58% -$251K ﹤0.01% 341
2024
Q1 		$433K Buy
2,008
+296
+17% +$69.3K ﹤0.01% 325
2023
Q4 		$443K Buy
1,712
+53
+3% +$13K ﹤0.01% 337
2023
Q3 		$426K Sell
1,659
-421
-20% -$113K ﹤0.01% 334
2023
Q2 		$592K Buy
2,080
+903
+77% +$269K ﹤0.01% 318
2023
Q1 		$327K Sell
1,177
-998
-46% -$276K ﹤0.01% 387
2022
Q4 		$602K Buy
2,175
+34
+2% +$9.6K ﹤0.01% 325
2022
Q3 		$572K Buy
2,141
+214
+11% +$45.4K ﹤0.01% 322
2022
Q2 		$393K Sell
1,927
-150
-7% -$30.7K ﹤0.01% 359
2022
Q1 		$437K Sell
2,077
-250
-11% -$54.4K ﹤0.01% 357
2021
Q4 		$558K Sell
2,327
-398
-15% -$102K ﹤0.01% 413
2021
Q3 		$771K Sell
2,725
-1,979
-42% -$649K ﹤0.01% 364
2021
Q2 		$1.63M Sell
4,704
-56,987
-92% -$17.3M 0.01% 305
2021
Q1 		$17.3M Sell
61,691
-3,910
-6% -$1.05M 0.13% 122
2020
Q4 		$16.1M Sell
65,601
-32,194
-33% -$8.31M 0.13% 114
2020
Q3 		$27.7M Sell
97,795
-13,176
-12% -$3.67M 0.27% 75
2020
Q2 		$29.6M Sell
110,971
-10,090
-8% -$3.03M 0.34% 67
2020
Q1 		$38.3M Buy
+121,061
New +$36.7M 0.89% 32

Other funds holding BIIB

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank Julius Baer & Co's BIIB Position: Q1 2026 in Review

Bank Julius Baer & Co held its Biogen (BIIB) position steady in Q1 2026 at 40 shares worth $7.35K. The position accounts for ﹤0.01% of the portfolio, ranked #654.

Bank Julius Baer & Co first reported a position in BIIB in Q1 2020 and has held it in 25 quarters since. The position peaked at $38.3M in Q1 2020. 1,008 funds tracked by Wall St. Rank hold BIIB as of Q1 2026.

  • Bank Julius Baer & Co held 40 shares of Biogen worth $7.35K as of Q1 2026.
  • Bank Julius Baer & Co left its Biogen share count unchanged in Q1 2026.
  • Biogen made up ﹤0.01% of Bank Julius Baer & Co's portfolio in Q1 2026, its #654 holding.
  • Bank Julius Baer & Co first reported a position in Biogen in Q1 2020 and has held it in 25 quarters since.
  • Bank Julius Baer & Co's Biogen position peaked at $38.3M in Q1 2020.
  • 1,008 funds tracked by Wall St. Rank held Biogen as of Q1 2026.

Based on Bank Julius Baer & Co's 13F filing for Q1 2026, filed 5 May 2026.